Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 175.49%10.35B | -1.67%15.57B | -37.98%3.76B | -49.80%15.83B | -61.00%6.06B | -1.59%31.54B | -19.94%15.53B | 70.45%32.05B | 370.78%19.4B | 26.03%18.8B |
| Operating income | 175.49%10.35B | -1.67%15.57B | -37.98%3.76B | -49.80%15.83B | -61.00%6.06B | -1.59%31.54B | -19.94%15.53B | 70.45%32.05B | 370.78%19.4B | 26.03%18.8B |
| Cost of sales | -221.10%-8.58B | -3.80%-11.13B | 32.80%-2.67B | 48.57%-10.72B | 53.69%-3.97B | -6.23%-20.85B | 29.08%-8.58B | -96.47%-19.62B | -373.58%-12.1B | -1.98%-9.99B |
| Operating expenses | -221.10%-8.58B | -3.80%-11.13B | 32.80%-2.67B | 48.57%-10.72B | 53.69%-3.97B | -6.23%-20.85B | 29.08%-8.58B | -96.47%-19.62B | -373.58%-12.1B | -1.98%-9.99B |
| Gross profit | 63.31%1.77B | -13.14%4.44B | -47.88%1.09B | -52.20%5.11B | -70.03%2.08B | -13.95%10.69B | -4.78%6.95B | 40.97%12.43B | 366.23%7.3B | 71.99%8.81B |
| Selling expenses | -43.98%-242.9M | 19.01%-416.79M | 8.11%-168.71M | -18.86%-514.59M | -12.88%-183.6M | -8.47%-432.94M | 4.97%-162.66M | -24.95%-399.14M | -115.27%-171.16M | 9.35%-319.44M |
| Administrative expenses | 17.89%-491.48M | 21.10%-1.2B | 9.42%-598.57M | 19.05%-1.52B | -0.17%-660.78M | -20.72%-1.87B | -12.93%-659.66M | -50.26%-1.55B | -152.89%-584.12M | 0.22%-1.03B |
| Revaluation surplus | -405.36%-98.55M | -145.16%-216.62M | -109.82%-19.5M | 167.77%479.63M | 164.51%198.66M | 89.56%-707.73M | 68.52%-307.96M | -491.33%-6.78B | -6.74%-978.31M | -166.13%-1.15B |
| -Changes in the fair value of investment property | -265.56%-99.67M | -141.08%-227.88M | -109.87%-27.27M | 257.62%554.65M | 1,268.43%276.22M | 13.25%-351.89M | 83.73%-23.64M | 40.09%-405.65M | 68.71%-145.28M | -148.61%-677.13M |
| -Changes in the fair value of financial assets | -85.60%1.12M | 115.00%11.25M | 110.01%7.76M | 78.92%-75.03M | 72.72%-77.56M | 94.42%-355.85M | 65.87%-284.32M | -1,257.87%-6.37B | -84.19%-833.04M | -237.79%-469.43M |
| Impairment and provision | 27.99%-10.36M | 66.43%-8.96M | -23.30%-14.39M | 65.39%-26.7M | 74.06%-11.67M | 81.19%-77.14M | -492.76%-45M | -6,471.36%-410.05M | --11.46M | ---6.24M |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---365.46M | ---- | ---- |
| -Other impairment is provision | 27.99%-10.36M | 66.43%-8.96M | -23.30%-14.39M | 65.39%-26.7M | 74.06%-11.67M | -72.97%-77.14M | -492.76%-45M | -614.68%-44.6M | --11.46M | ---6.24M |
| Special items of operating profit | -479.35%-225.58M | 496.28%127.93M | 59.13%-38.94M | -124.90%-32.28M | -143.35%-95.26M | 1,243.17%129.66M | 10.48%219.76M | -99.29%9.65M | -76.19%198.91M | 598.00%1.35B |
| Operating profit | 186.65%704.39M | -22.06%2.73B | -81.53%245.73M | -54.73%3.5B | -77.81%1.33B | 134.68%7.73B | 3.78%6B | -57.00%3.29B | 391.99%5.78B | 65.14%7.66B |
| Financing income | -46.44%43.44M | -32.34%137.75M | -4.58%81.1M | -6.01%203.58M | -35.48%85M | -12.59%216.59M | 22.56%131.73M | 17.46%247.79M | --107.48M | --210.96M |
| Financing cost | -1.23%-731.13M | -10.97%-1.38B | -24.66%-722.25M | -28.12%-1.24B | -23.43%-579.38M | -31.77%-971.69M | -17.93%-469.41M | 25.67%-737.39M | 32.66%-398.03M | ---992.04M |
| Share of profit from joint venture company | -249.46%-1.92B | -66.31%-1.14B | -74.72%-550.43M | -274.41%-682.7M | -323.53%-315.03M | -53.59%391.44M | -16.54%140.93M | -32.75%843.45M | 20.59%168.87M | --1.25B |
| Special items of earning before tax | ---- | ---1.17B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | -101.60%-1.91B | -146.30%-822.19M | -281.48%-945.85M | -75.89%1.78B | -91.01%521.2M | 101.95%7.37B | 2.54%5.8B | -55.15%3.65B | 682.02%5.66B | 21.68%8.13B |
| Tax | -206.34%-600.46M | 54.81%-715.17M | 64.82%-196.01M | 67.78%-1.58B | 83.30%-557.22M | 14.55%-4.91B | 12.23%-3.34B | -37.84%-5.75B | -971.55%-3.8B | -80.74%-4.17B |
| After-tax profit from continuing operations | -119.58%-2.51B | -894.93%-1.54B | -3,070.34%-1.14B | -92.12%193.4M | -101.46%-36.02M | 216.91%2.46B | 32.79%2.46B | -152.99%-2.1B | 403.34%1.85B | -9.45%3.96B |
| Earning after tax | -119.58%-2.51B | -894.93%-1.54B | -3,070.34%-1.14B | -92.12%193.4M | -101.46%-36.02M | 216.91%2.46B | 32.79%2.46B | -152.99%-2.1B | 403.34%1.85B | -9.45%3.96B |
| Minority profit | 371.89%110.71M | -37.29%285.22M | -150.52%-40.72M | 22.94%454.79M | -21.26%80.6M | -40.49%369.93M | -77.83%102.37M | 158.33%621.63M | 905.67%461.8M | -23.49%240.63M |
| Profit attributable to shareholders | -137.76%-2.62B | -597.25%-1.82B | -844.26%-1.1B | -112.53%-261.4M | -104.94%-116.62M | 176.62%2.09B | 69.47%2.36B | -173.11%-2.72B | 331.83%1.39B | -8.37%3.72B |
| Basic earnings per share | -137.83%-0.2942 | -596.60%-0.2048 | -844.27%-0.1237 | -112.55%-0.0294 | -104.94%-0.0131 | 176.62%0.2343 | 69.52%0.2653 | -172.76%-0.3058 | 328.77%0.1565 | -11.57%0.4203 |
| Diluted earnings per share | -137.83%-0.2942 | -596.60%-0.2048 | -844.27%-0.1237 | -112.55%-0.0294 | -104.94%-0.0131 | 176.62%0.2343 | 69.52%0.2653 | -172.76%-0.3058 | 328.77%0.1565 | -11.57%0.4203 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.